This prospective ICU registry study examined whether culture-confirmed Staphylococcus aureus pneumonia encompasses clinically meaningful microbiome heterogeneity in the lower respiratory tract. The investigators applied 16S rRNA gene sequencing and shotgun nanopore metagenomics to endotracheal aspirate samples from mechanically ventilated patients with culture-confirmed S. aureus pneumonia to quantify bacterial abundance, assess relationships with routine culture data and host inflammatory biomarkers, and test associations with 60-day mortality.
Endotracheal aspirate samples from mechanically ventilated patients with culture-confirmed S. aureus pneumonia were analyzed. The study performed 16S sequencing on 54 samples and nanopore shotgun metagenomics on 28 samples drawn from a cohort of 109 patients overall. The team quantified Staphylococcus relative abundance using 16S data and absolute S. aureus read counts from nanopore data. They compared sequencing-derived measures with semi-quantitative culture growth and methicillin resistance results, evaluated correlations with host inflammatory biomarkers, and tested associations with 60-day survival using Kaplan-Meier and Cox proportional hazards models with adjustment for age, sex, and methicillin resistance where indicated.
Among the 109 patients in the registry, traditional culture features—specifically semi-quantitative growth and methicillin resistance—did not show associations with 60-day outcomes. This observation motivated deeper microbial profiling to determine whether culture positivity masks heterogeneity in pathogen burden or community composition that might carry prognostic information.
Analysis of the 54 samples by 16S sequencing revealed substantial heterogeneity in Staphylococcus relative abundance, ranging from 0% to 96.7%. Only one-third (33%) of sequenced samples met the study definition of dominance (>50% relative abundance). Patients whose lower airway microbiome was dominated by Staphylococcus had worse 60-day survival compared with non-dominant patients (50% vs 80%, p=0.013). In multivariable Cox models adjusting for age, sex, and methicillin resistance, Staphylococcus dominance remained an independent predictor of mortality (adjusted hazard ratio 3.24, 95% CI 1.12–9.36, p=0.030).
The Staphylococcus-dominant phenotype was associated with a distinct host inflammatory profile. Dominant patients exhibited higher levels of pentraxin-3 (p=0.01) and lower levels of fractalkine (p=0.02) relative to non-dominant cases, consistent with a dysregulated or hyperinflammatory host response accompanying high bacterial burden.
Nanopore shotgun metagenomic sequencing on 28 samples validated the 16S-based observations. High absolute S. aureus read counts by nanopore sequencing independently predicted mortality with a larger effect size (adjusted HR 11.23, 95% CI 2.25–55.9, p=0.003), reinforcing that greater bacterial burden in the lower respiratory tract identifies a higher-risk subgroup among patients with culture-confirmed S. aureus pneumonia.
In an exploratory analysis of virulence determinants performed on a subset (n=19), detection of the virulence gene staphylokinase was associated with the hyperinflammatory phenotype (p=0.003) and with increased mortality (p=0.046). The authors present these results as hypothesis-generating, noting the limited sample size for this subanalysis.
This study demonstrates that conventional culture positivity for S. aureus does not equate to a uniform biological or clinical entity. Metagenomic and 16S profiling reveal a microbiome-defined subset—characterized by Staphylococcus dominance and higher bacterial burden—that carries worse survival and a dysregulated host inflammatory signature. Semi-quantitative culture growth and methicillin resistance did not discriminate risk, whereas sequence-based measures of abundance did, including an adjusted hazard ratio of 3.24 for dominance by 16S and 11.23 for high absolute reads by nanopore metagenomics.
These findings suggest that integrating sequencing-based assessment of lower respiratory tract bacterial burden and targeted virulence gene detection may improve risk stratification in mechanically ventilated patients with culture-confirmed S. aureus pneumonia. The exploratory association between staphylokinase and a hyperinflammatory, higher-mortality phenotype warrants further study in larger cohorts.
Limitations reported in the source include the sample sizes for sequencing subgroups and exploratory virulence analyses; raw clinical data were restricted but derived datasets and code are available per the authors' data availability statement. The authors conclude that microbiome and metagenomic profiling can unmask prognostically relevant heterogeneity concealed by standard diagnostics and identify a high-risk phenotype among culture-positive S. aureus pneumonia cases.